Earnings Call · Q1 FY2022·2022-05-04

Q1 22EPS -39.84%·Rev n/aQ4 21EPS +41.61%·Rev n/aQ3 21EPS -22.32%·Rev n/aQ2 21EPS -18.26%·Rev n/a⚠ consensus missing

REGENXBIO Inc. RGNX

Patrick Christmas — Investor Relations or Communications (inferred from role of introducing executives and managing call)

Ken Mills — President and Chief Executive Officer

Steve Pakola — Chief Medical Officer

Vit Vasista — Chief Financial Officer

−14.9%1d on move date−11.4% vs SPY3d−29.6%5d−31.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RGNX calls or request research access.

More RGNX calls Browse calls Request research access